With the rapid pace of immunologic research, it is more important than ever for readers to understand rational immunodiagnosis, immunopro-phylaxis, and immunotherapy. This column is intended to help you ensure proper immunologic drug use in your practice.
Get full access to this article
View all access options for this article.
References
1.
United Network for Organ Sharing; Richmond, VA. http://www.unos.org. Accessed September 21, 1998.
2.
National Marrow Donor Program; Minneapolis, MN. http://www.marrow.org. Accessed September 21, 1998.
3.
HorowitzM.M., RowlingsP.A.An update from the International Bone Marrow Transplant Registry and the Autolo-gous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol.1997; 4: 395–400.
4.
GershonA.A.Immunizations for pediatric transplant recipients. Kidney Internat.1993; 44: S87–S90.
5.
AveryR.K.Infections and immunizations in organ transplant recipients: A preventive approach. Cleveland Clin J Med.1994; 61: 386–92.
6.
FishmanJ.A., RubinR.H.Infection in organ-transplant recipients. N Engl J Med.1998; 338: 1741–51.
7.
MuñozS.J.Long-term management of the liver transplant recipient. Med Clin N Amer.1996; 80: 1103–20.
8.
DuncombeA.ABC of clinical haema-tology: Bone marrow and stem cell transplantation. BMJ.1997; 314: 1179–82.
9.
WingardJ.R.Advances in the management of infectious complications after bone marrow transplantation. Bone Marrow Transplant.1990; 6: 371–83.
10.
AmbrosinoD.M., MolrineD.C.Critical appraisal of immunization strategies for prevention of infection in the compromised host. Hemat/Oncol Clin N Amer.1993; 7: 1027–50.
11.
LenarskyC.Mechanisms in immune recovery after bone marrow transplantation: Management of posttransplant immune deficiency. Am J Pediatr Hema-tol/Oncol.1993; 15: 49–55.
12.
SomaniJ., LarsonR.A.Reimmunization after allogeneic bone marrow transplantation. Am J Med.1995; 98: 389–98.
13.
WimperisJ.Z., BrennerM.K., PrenticeH.G., ReittieJ.E., KarayiannisP., GriffithsP.D., HoffbrandA.V.Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet.1986; 1: 339–43.
14.
PeterG., ed. 1997 Red Book: Report of the Committee on Infectious Diseases.24th ed.Elk Grove Village, IL: American Academy of Pediatrics; 1997.
15.
American College of Physicians. Guide for Adult Immunization.3rd ed.Philadelphia, PA: American College of Physicians; 1994.
16.
Centers for Disease Control and Prevention. Recommended childhood immunization schedule—United States, 1999. MMWR.1999; 48: 8–16.
17.
GrabensteinJ.D.ImmunoFacts: Vaccines and Immunologic Drugs.St. Louis, MO: Facts and Comparisons; May 1999.
18.
ThallT.V., RoshJr, SchwersenzA.H., EickmeyerD., FernandezM., BenkovK.J., LeLeikoN.S.Primary immunization status in infants referred for liver transplantation. Transplant Proc.1994; 26: 191.
19.
LjungmanP., CordonnierC., deBockR., EinseleH., EngelhardD., GrundyJ., LinkH., LocasciulliA., PrenticeG., ReusserP., Rib-audP., Infectious Diseases Working Party of EBMT. Immunizations after bone marrow transplantation: Results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant.1995; 15: 455–60.
20.
HenningK.J., WhiteM.H., SepkowitzK.A., ArmstrongD.A national survey of immunization practices following allo-geneic bone marrow transplantation. JAMA.1997; 277: 1148–51.
21.
FurthS.L., NeuA.M., SullivanE.K., GenslerG., TejaniA., FivushB.A.Immunization practices in children with renal disease: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol.1997; 11: 443–46.
22.
Advisory Committee on Immunization Practices. Use of vaccines and immune globulins in persons with altered immuno-competence. MMWR.1993; 42(RR-4): 1–18.
23.
WelchT.R., BalistreriW., DanielsS.Care of the child with a solid organ transplant: What is the role of the generalist?J Pediatr.1997; 130: 850–1.
Advisory Committee on Immunization Practices. Prevention and control of influenza. MMWR.1998; 47(RR-6): 1–25.
27.
RytelM.W., DaileyM.P., SchiffmanG., HoffmannR.G., PieringW.F.Pneumococ-cal vaccine immunization of patients with renal impairment. Proc Soc Exp Biol Med.1986; 182: 468–73.
28.
SixbeyJ.W.Routine immunizations and the immunosuppressed child. Adv Pediatr Infect Dis.1987; 2: 79–114.
29.
HibberdP.L., RubinR.H.Approach to immunization in the immunosuppressed host. Infect Dis Clin N Amer.1990; 4: 123–42.
30.
GenneryA.R., CantA.J., SpickettG.P., WalshawD., HunterS., HasanA., HamiltonJ.R.L., DarkJ.Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen. Lancet.1998; 351: 177–81.
31.
CosioF.G., GiebinkG.S., LeC.T., Schiff-manG.Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients. Kidney Internat.1981; 20: 254–8.
32.
LinnemannC.C.Jr., FirstM.R., Schiff-manG.Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med.1981; 141: 1637–40.
33.
WinstonD.J., HoW.G., SchiffmanG., ChamplinR.E., FeigS.A., GaleR.P.Pneu-mococcal vaccination of recipients of bone marrow transplants. Arch Intern Med.1983; 143: 1735–7.
34.
ArnoldW.C., SteeleR.W., RastogiS.P., FlaniganW.J.Response to pneumococcal vaccine in renal allograft recipients. Am J Nephrol.1985; 5: 30–4.
35.
HammarstömV., PauksenK., AzingeJ., ÖbergG., LjungmanP.Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: The influence of graft versus host reaction. Support Care Cancer.1993; 1: 195–9.
36.
LinnemannC.C.Jr., FirstM.R., Schiff-manG.Revaccination of renal transplant and hemodialysis recipients with pneu-mococcal vaccine. Arch Intern Med.1986; 146: 1554–6.
37.
MolrineD.C., GuinanE.C., AntinJ.H., WheelerC., ParsonsS.K., WeinsteinH.J., McGarigleC., BlandingP., PhillipsN.R., Cia-marraA., GeorgeS., AmbrosinoD.M.Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation. Bone Marrow Transplant.1996; 17: 1149–55.
38.
LjungmanP., Wiklund-HammarstenM., DurajV., HammarstömL., LönnqvistB., PaulinT., RingdénO., PepeM.S., GahrtonG.Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis.1990; 162: 496–500.
39.
GottliebD.J., CryzS.J., FürerE., QueJ.U., PrenticeH.G., DuncombeA.S., BrennerM.K.Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients. Blood.1990; 76: 2470–5.
40.
EngelhardD., NaglerA., HardanI., MoragA., AkerM., BaciuH., StraussN., ParagG., NaparstekE., RavidZ., OrR., SlavinS., Zakay-RonesZ.Antibody response to a two-dose regimen of influenza vaccine in allogeneic T-cell depleted and autologous BMT recipients. Bone Marrow Transplant.1993; 11: 1–5.
41.
IlanY., NaglerA., AdlerR., NaparstekE., OrR., SlavinS., BrautbarC., ShouvalD.Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology.1993; 18: 246–52.
42.
TurikM.A., MarkowitzS.M.A successful regimen for the prevention of seroconversion after transplantation of a heart positive for hepatitis B surface antigen. J Heart Lung Transplant.1992; 11: 781–3.
43.
Advisory Committee on Immunization Practices. Prevention of hepatitis A through active or passive immunization. MMWR.1996; 45(RR-15): 1–30.
44.
BerenguerM., WrightT.L.Are HCV-infected individuals candidates for hepatitis A vaccine?Lancet.1998; 351: 924–5.
45.
LjungmanP., DurajV., MagniusL.Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant.1991; 7: 89–93.
46.
PauksenK., HammarstömV., LjungmanP., SjölinJ., ÖbergG., LönnerholmG., MagniusL., SimonssonB.Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect
